143 Afleveringen

  1. Immunotherapy rechallenge in NSCLC

    Gepubliceerd: 3-3-2022
  2. ESO’s career development programme

    Gepubliceerd: 24-2-2022
  3. Summary/Review - Reporting Guidelines - CONSORT

    Gepubliceerd: 17-2-2022
  4. Summary/Review: Long-term results of SNB after NCT for primary cN1/2 breast who convert to cN0

    Gepubliceerd: 10-2-2022
  5. Summary/Review: Pathology after neoadjuvant treatment for breast cancer – How to assess residual disease.

    Gepubliceerd: 3-2-2022
  6. Intraoperative breast ultrasound

    Gepubliceerd: 27-1-2022
  7. Summary/Review - Reporting Guidelines - PRISMA 2020

    Gepubliceerd: 20-1-2022
  8. Summary/Review - The use of Artificial Intelligence in the Oncology field. Addressing all the hype and skepticism.

    Gepubliceerd: 13-1-2022
  9. Advanced Gastric Cancer

    Gepubliceerd: 9-12-2021
  10. PARP inhibitors for the treatment of ovarian cancer

    Gepubliceerd: 2-12-2021
  11. The role of clinician-scientists in modern oncology

    Gepubliceerd: 25-11-2021
  12. Pharmacologic interactions with new drugs

    Gepubliceerd: 18-11-2021
  13. Positive Resection Margins in Colon Cancer

    Gepubliceerd: 11-11-2021
  14. Immunotherapy in Lung Cancer

    Gepubliceerd: 4-11-2021
  15. Low HR positive breast cancer

    Gepubliceerd: 28-10-2021
  16. Possibilities of tackling side effects of cancer therapies

    Gepubliceerd: 21-10-2021
  17. Fertility preservation in young cancer patients

    Gepubliceerd: 14-10-2021
  18. CDK4/6i in HR+HER2- breast cancer

    Gepubliceerd: 7-10-2021
  19. Treatment selection in castration-resistant prostate cancer

    Gepubliceerd: 30-9-2021
  20. Questions and Controversies in Localized Head and Neck Cancer

    Gepubliceerd: 23-9-2021

6 / 8

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net

Visit the podcast's native language site